Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks presents investors with the better value opportun
The year-over-year growth in Breast Health and GYN Surgical Businesses contributed to Hologic's (HOLX) Q2 revenues.
Hologic, Inc. (NASDAQ:HOLX ) Q2 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conf
Although the revenue and EPS for Hologic (HOLX) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street
Hologic (HOLX) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $2.07 per share a year ago.
Hologic: A Superb Steward Of Capital, Offsets Top-Line Risks
Here is how Hologic (HOLX) and Ligand Pharmaceuticals (LGND) have performed compared to their sector so far this year.
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Edwards Lifesciences (EW). But which of these two stocks presents investors with the better v
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AutoNation (AN), Suzano (SUZ), Valero Energy (VLO), Hologic (HOLX) and Ryder (R) are some of the stocks with high ROE to profit from as markets rise despite lower oil production.
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #2QFY23--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2023 on Mon
Hologic (HOLX) is currently well-positioned to achieve its full-year guidance of low double-digit organic growth ex-COVID in all three franchises, well above the 5-7% long-term growth rate.
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE